Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease.
Lustig R; Mikkelsen T; Lesser G; Grossman S; Ye X; Desideri S; Fisher J; Wright J; Neuro-Oncology, 2008, vol. 10, issue 6, p 1004, ISSN 15228517. ISBN 15228517.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef